Klotho Neurosciences, Inc.
KLTO
$0.7488
$0.068810.12%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -83.22% | -8.06% | 30.14% | -555.31% | 32.80% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 125.52% | 40.64% | -57.41% | 4,679.50% | -86.08% |
| Change in Net Operating Assets | 1.57% | -250.50% | 1,316.14% | 94.88% | -236.63% |
| Cash from Operations | -26.69% | -64.55% | 12.00% | -18.25% | -4,024.55% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | 100.00% |
| Cash from Investing | -- | -- | -- | -- | 100.00% |
| Total Debt Issued | -98.64% | 77.20% | 698.00% | -84.21% | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 315.64% | 45.67% | -193.39% | -83.32% | -- |
| Cash from Financing | 378.31% | 114.83% | 243.63% | -83.81% | 883.09% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1,466.44% | 3,822.66% | 101.61% | -197.71% | 2,655.93% |